BRUSSELS (Reuters) - Belgian biotech company ThromboGenics said on Thursday that U.S. health regulators had approved the use of its main drug, eye treatment Jetrea.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment